SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002371
Filing Date
2020-04-17
Accepted
2020-04-16 18:27:28
Documents
1
Period of Report
2020-06-04
Effectiveness Date
2020-04-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241378zdef14a.htm DEF 14A 353293
  Complete submission text file 0001047469-20-002371.txt   354306
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38630 | Film No.: 20797354
SIC: 2834 Pharmaceutical Preparations